Index - 28 - 29 - 30/31 - 32/33/34 - 35 - 36/37/38/39 - 40/41 - 42/43 - 44/45/46 - 47/48 - 49 - 50/51/52/53
54/55 - 56 - 57/58 - 59 - 60/61 - 62 - Pages online: A - B - C - D - E - F - G - References
NEUROCOGNITIVE IMPAIRMENT: DIAGNOSIS AND MANAGEMENT

Any HIV-infected person complaining of disturbances in his/her memory (comprehension, clarity or speed) should be evaluated extensively, including neurological examination, neuropsychological assessment, cerebrospinal examination and imaging of the brain.

  • Patients without such symptoms that should be targeted for screening
    • Uncontrolled HIV infection (detectable plasma HIV RNA)
    • Use of antiretroviral agents with limited CNS penetration
    • Low CD4 nadir (<200 cells/mm3)
    • Ongoing depression
  • Screening tool
    • International HIV Dementia Scale (IHDS)i
  • Interventions if neurocognitive impairment detected:
    • If patient is not on ART:
      • Consider initiation of ART in which at least 2 drugs penetrate CNSii
      • Consider risk for antiretroviral resistance if prior virological failure
    • If patient is already on ART:
      • Consider changing antiretroviral treatment to active drugs with better CNS penetrationii
      • Consider genotyping of plasma and CSF HIV RNA whenever feasible prior to changing ART

i See www.europeanaidsclinicalsociety.org/guide/index.htm for components of the IHDS scale
ii See www.europeanaidsclinicalsociety.org/guide/index.htm for list of drugs with favourable and poor CNS penetration